Targeting mTOR in myeloid cells prevents infection-associated inflammation
Authors:
Open Access
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases Division of Intramural Research (R01 DK130425, R01 AI160706)
- Engineering Research Centers (101019807)
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (91818622, 19681)
- Leducq Foundation
- National Institute of Allergy and Infectious Diseases
- HORIZON EUROPE Health (EPIC-CROWN-2)
- Hellenic Institute for the Study of Sepsis
- Horizon 2020
- European Research Council
- National Heart Lung and Blood Institute Division of Intramural Research
This publication has 113 references indexed in Scilit:
- Is there any role of intermittent fasting in the prevention and improving clinical outcomes of COVID-19?: intersection between inflammation, mTOR pathway, autophagy and calorie restrictionVirusDisease, 2021
- mTOR inhibition: a double-edged sword in patients with COVID-19?Human Cell, 2021
- mTOR inhibition in COVID‐19: A commentary and review of efficacy in RNA virusesJournal of Medical Virology, 2020
- Clinical implications of increased uptake in bone marrow and spleen on FDG-PET in patients with bacteremiaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2020
- Emerging pharmacological therapies for ARDS: COVID-19 and beyondIntensive Care Medicine, 2020
- Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, ChinaIntensive Care Medicine, 2020
- Review: Cytokine Storm Syndrome: Looking Toward the Precision Medicine EraArthritis & Rheumatology, 2017
- Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 CountriesJAMA, 2016
- The ALIEN study: incidence and outcome of acute respiratory distress syndrome in the era of lung protective ventilationIntensive Care Medicine, 2011
- Endotoxins: Lipopolysaccharides of Gram-Negative Bacteria2010